Regulatory trust Aarti Drugs positions itself as a trusted EU-compliant API partner with strong regulatory support, including dossiers and DMFs, offering an opportunity to target pharma manufacturers seeking reliable, compliant API sourcing for regulated markets.

Anti-Inflammatory Focus Specialization in anti-inflammatory APIs such as aceclofenac, celecoxib, diclofenac, and nimesulide presents a ready-made cross-sell for formulators and generic manufacturers targeting pain and inflammatory disease therapies.

Global export readiness With seamless export capabilities, an experienced logistics team, and EU-compliant facilities, there’s a sales path to European and global partners needing dependable API supply chains and flexible delivery formats.

Growth trajectory Recent revenue projections and near-term EBITDA growth indicate improving financial performance, suggesting capacity to take on larger contracts or multi-year supply agreements with pharmaceutical players.

R&D collaboration Free development samples and strong documentation support create opportunities for early-stage testing partnerships, enabling faster onboarding of new formulations and potential long-term API supply deals.